FIELD: biotechnology.
SUBSTANCE: method of assessment of activity of therapeutic and prophylactic preparations against natural smallpox comprises administering to an animal model of control and test groups in a predetermined scheme of suspension of the antiviral preparation under study, their intranasal infection with a strain of natural smallpox virus, incubation of the virus in animal bodies and determining the concentration of virus in the lungs of animals with the subsequent calculation of estimate values of decrease in the concentration of virus in lungs. The preparation is administered to animal bodies one day prior to infecting, on the day of infecting and every day during the time of the virus incubation. The animal models are used as outbred white mice ICR of different sexes weighing 7-9 g. The strain of natural smallpox virus is used as the strain India-3a deposited at the National Collection of pathogens of viral infections and rickettsioses of the Federal budget institution of science State Research Centre of Virology and Biotechnology "Vector" under the registration number V-45.
EFFECT: adequate representation of human natural smallpox disease with use of highly virulent strain of natural smallpox virus and animal model.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ASSESSMENT OF ACTIVITY OF MEDICAL AND PREVENTIVE DRUGS AGAINST SMALLPOX VIRUS | 2014 |
|
RU2565812C1 |
MEDICATED PRODUCT FOR SMALLPOX VIRUS AND METHOD FOR PRODUCING AND USING IT | 2013 |
|
RU2543338C1 |
METHOD FOR ASSESSING ANTISMALLPOX ACTIVITY OF THERAPEUTIC PREPARATIONS | 2012 |
|
RU2496149C1 |
METHOD OF EVALUATION OF ANTIVARIOLIC ACTIVITY OF THERAPEUTIC AND PROPHYLACTIC PREPARATIONS | 2013 |
|
RU2526504C1 |
ORAL DOSAGE FORM OF THE PREPARATION IN CAPSULES FOR TREATING AND PREVENTING ORTHOPOXVIRUS-RELATED DISEASES | 2019 |
|
RU2716709C1 |
SMALLPOX VIRAL STRAIN GPA FOR STUDYING EFFICACY OF ANTIVIRAL PREPARATIONS in vivo AND ASSESSING REDUCTION ROUTINES UNDESIRED VACCINE REACTIONS ACCOMPANYING PRIMARY SMALLPOX VACCINATION | 2013 |
|
RU2542400C1 |
STRAIN A/Salekhard/01/2009(H1N1)v OF SUBTYPE H1N1 INFLUENZA A VIRUS FOR STUDYING THERAPEUTIC AND PROPHYLACTIC EFFICACY OF PREPARATIONS FOR INFLUENZA VIRUS | 2011 |
|
RU2457242C1 |
AGENT FOR ARRESTING UNDESIRABLE VACCINAL REACTIONS AND COMPLICATIONS DURING PRIMARY VACCINATION WITH VARIOLAR VACCINES AND METHOD FOR USE THEREOF | 2013 |
|
RU2542490C1 |
STRAIN OF BIRD FLU VIRUS A/CHICKEN/KURGAN/05/2005 SUBTYPE H5N1 FOR STUDYING OF ACTIVITY OF MEDICAL AND PREVENTIVE PREPARATIONS AGAINST FLU VIRUS | 2008 |
|
RU2361917C1 |
METHOD FOR BODY PROTECTION AGAINST INFECTION CAUSED BY INFLUENZA A VIRUS SUBTYPE H1N1 STRAINS WITH PREPARATION OF HUMAN ALPHA-2 INTERFERON | 2013 |
|
RU2523554C1 |
Authors
Dates
2014-07-20—Published
2013-09-09—Filed